TET2 and acute myeloid leukemia: Mutations in U2AF1, RUNX1 and TET2 were significantly enriched only in AML‐MRC‐H compared to AML‐MRC‐C (p = 0.042, p = 0.0043 and p = 0.0040, respectively).